NEW YORK (GenomeWeb News) – UK science services firm LGC today announced it has acquired KBioscience for an undisclosed amount.
LGC's Genomics division and KBioscience will be combined to offer genomic services and solutions, LGC said. KBioscience provides genotyping services, chemistries, and related products, and the acquisition extends and LGC's genomics services and products.
The deal also further's LGC Genomics' goal to become Europe's leading provider of genomic services, LGC added.
Based in the UK, KBioscience was founded in 2002 and develops genotyping assays using its fluorescence-based competitive allele-specific PCR technique called KASP. LGC's products and services in DNA sequencing and extraction are complementary to the systems and products developed by KBioscience.
Its founders remain partners and significant shareholders in the company, LGC said.